Table 2 GI JEV VLP-vaccinated pigs challenged with GI and GIII viruses.
Immunogens | JEV challenge | Viremiaa | Tonsilsb | Lymph nodes | Brain | Body temperaturec | Fold increase in FRμNT50d | |
---|---|---|---|---|---|---|---|---|
Viral titers (ffu/ml) (mean ± SD) | Viral RNA (copies/ml) (mean ± SD) | Viral RNA (copies/g) (mean ± SD) | ||||||
PBS | YL2009-4 | 3.6 ± 0.1 | 6.3 ± 0.5 | 7.1 ± 0.3 | 6.1 ± 0.2 | 5.0 ± 0.4 | 40.7 | 1093.0* |
PBS | YL2009-4 | 3.4 ± 0.1 | 5.6 ± 0.3 | 6.3 ± 1.2 | 4.5 ± 0.1 | 5.2 ± 0.4 | 40.8 | 938.0* |
PBS | YL2009-4 | 4.6 ± 0.2 | 7.1 ± 0.2 | 6.9 ± 0.1 | 7.0 ± 0.2 | 5.8 ± 0.3 | 41.1 | 1966.6* |
PBS | YL2009-4 | 4.7 ± 0.2 | 6.3 ± 0.3 | 7.2 ± 0.5 | 6.7 ± 0.3 | 5.1 ± 0.1 | 40.7 | 1698.2* |
PBS | CH1392 | 2.8 ± 0.2 | 5.8 ± 0.2 | 5.6 ± 1.3 | 4.2 ± 0.1 | 4.5 ± 0.5 | 40.2 | 2048.0* |
PBS | CH1392 | 2.5 ± 0.2 | 5.1 ± 0.1 | 6.1 ± 0.1 | 4.5 ± 0.1 | 4.6 ± 0.3 | 39.8 | 1220.6* |
PBS | CH1392 | 2.5 ± 0.3 | 5.6 ± 0.4 | 6.2 ± 0.4 | 4.8 ± 0.2 | 5.1 ± 0.1 | 39.9 | 814.8* |
PBS | CH1392 | 2.8 ± 0.2 | 5.8 ± 0.1 | 6.6 ± 0.2 | 5.2 ± 0.1 | 5.2 ± 0.2 | 39.5 | 1367.0* |
GI VLP | YL2009-4 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.3 | 0.8 |
GI VLP | YL2009-4 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.4 | 3.6 |
GI VLP | YL2009-4 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.1 | 1.6 |
GI VLP | YL2009-4 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.5 | 9.3* |
GI VLP | CH1392 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 37.8 | 0.4 |
GI VLP | CH1392 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 37.9 | 0.3 |
GI VLP | CH1392 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.2 | 1.3 |
GI VLP | CH1392 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 37.9 | 3.3 |
GI VLP | CH1392 | <1.3 | <2.0 | <2.0 | <2.0 | <2.0 | 38.5 | 6.6* |